Anger at NICE oral MS drug Gilenya decision
Posted: Tue Dec 06, 2011 12:29 am
Campaigners have condemned a decision that could lead to a ban on the use of the first pill to treat multiple sclerosis.
The National Institute of Health and Clinical Excellence (NICE) ruled the drug was too expensive following a second consultation on its use.
It says it is not minded to make it available on the NHS but a final decision has not been made yet and people can still make their views known.
It is believed the fingolimod, which is taken daily, can cut relapses in the condition, and it has been used successfully in other countries.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309